Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Clinical trial NCT00875238 · COMPLETED

Trial details

NCT number: NCT00875238
Sponsor: Vanderbilt University
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Cardiac Toxicity Cardiovascular Complications

Start date: 2008-06-01
Primary completion: 2015-03-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.